One step closer to tailored cancer treatments
07 September, 2016 by Adam FloranceThe goal of tailoring cancer treatments for individuals based on their genetic make-up is one step closer thanks to a comprehensive global study conducted by Cancer Council Victoria and University of Melbourne researchers.
Alcoholics are missing an important enzyme
06 September, 2016Researchers have identified an enzyme whose production is turned off in nerve cells of the frontal lobe when alcohol dependence develops, leading to continued use of alcohol despite adverse consequences.
Devils could be evolving resistance to DFTD
31 August, 2016Twenty years after the first case of devil facial tumour disease (DFTD) emerged, causing populations of Tasmanian devils to decline by at least 80%, the animals appear to be fighting back.
Bioinformatics events on the horizon
26 August, 2016EMBL Australia has announced two upcoming events that will be of interest to bioinformaticians, computational biologists and biomedical researchers.
Bad blood: chronic inflammation and suicide risk
24 August, 2016An international research collaboration has discovered the enzyme that contributes to chronic inflammation in the blood of patients with suicidal tendencies.
The role of cell death in a rare autoimmune disease
16 August, 2016Scientists have shown for the first time the important and different role played by the proteins MLKL and RIPK3 as regulators of the necroptotic process in a preclinical model of autoimmune disease.
Bioinformatics partnership to tailor cancer treatments
12 August, 2016The Pacific Northwest Research Institute has announced a strategic collaboration with Indivumed, a German oncology research company, designed to harness the power of molecular and clinical cancer data for tailoring successful treatments for individual cancer patients.
Synthetic DNA sequences improve genomic analysis
10 August, 2016Scientists at the Garvan Institute of Medical Research have led the development of a new technology based on synthetic human genome sequences.
Australia's first whole-genome testing service
27 July, 2016The Kinghorn Centre for Clinical Genomics has launched Australia's first clinical whole-genome sequencing service, with the potential to triple the diagnosis rates for Australians living with rare and genetic conditions.
Identifying kidney fibrosis risk
25 July, 2016 by Adam FloranceResearchers have identified a set of 13 genes that enable them to determine those kidney transplant patients who are 2–3 times more likely to develop fibrosis.
Genomics Innovation Hub to enable personalised cancer treatment
19 July, 2016The University of Melbourne and the Australian Genomics Research Facility have launched the Genomics Innovation Hub — a collaborative initiative that will help pave the way for personalised cancer treatments based on patients' genetic profiles.
Attacking the root cause of lung cancer
13 July, 2016Singaporean scientists have discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer.
Preventing malaria by removing proteins
07 July, 2016Researchers from the Walter and Eliza Hall Institute have shown that the malaria parasite cannot penetrate a human red blood cell when key proteins are deleted.
The key to regrowing limbs may be in our RNA
04 July, 2016 by Adam FloranceA new study has looked into limb regrowth and determined that microRNA may be the key to determining how and why a variety of otherwise seemingly unrelated species are able to regrow certain body parts.
Genomic analysis of malaria offers new insights
30 June, 2016An international research team has performed the first large-scale genomic analysis of Plasmodium vivax malaria infections — analysis that has improved our understanding of how the malaria parasite evolves and could boost efforts to control the disease.
